Decreased GABA+ Levels in the Medial Prefrontal Cortex of Perimenopausal Women: A 3T 1H-MRS Study
International Journal of Neuropsychopharmacology · 19.01.2023 · 26 (1) · 32-41
DOI: 10.1093/ijnp/pyac066 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 23.09.2022. Verfasst von Kim H Tran und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Alberta, Department of Psychiatry, Edmonton, AB, Canada. Hauptthemen laut MEDLINE: Perimenopause, Major Depressive Disorder. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Perimenopause is associated with an increased risk of developing a major depressive (MD) episode. A significant number of women develop their first MD episode during perimenopause, suggesting a unique pathophysiology of perimenopausal (PM) depression. Previous research has shown that depression is associated with decreased gamma-aminobutyric acid (GABA) levels in the medial prefrontal cortex (MPFC) of MD patients. The objective of this study was to compare MPFC GABA+ levels in healthy reproductive-aged (RD) and PM women.
Methods
A total of 18 healthy PM and 20 RD women were included in the study. MPFC GABA+ levels, which include homocarnosine and macromolecules, were measured via magnetic resonance spectroscopy using a 3 Tesla magnet. MPFC GABA+ levels were referenced to creatine + phosphocreatine (Cr+PCr). Absence of current or past psychiatric diagnosis was confirmed via a structured interview. RD participants were scanned during the early follicular phase of the menstrual cycle. PM women were scanned outside of ovulatory cycles.
Results
Mean MPFC GABA+ concentrations (relative to Cr+PCr) were decreased in the PM group compared with the RD group (PM mean = 0.08 ± 0.02, RD mean = 0.09 ± 0.02, t = −2.03, df = 36, P = .05) even after correcting for in percentage in gray matter (GM). Because PM women were inherently older than RD women (aged 48.8 ± 3.55 and 31.5 ± 9.66 years, respectively), the age difference between the 2 groups was statistically significant (P < .001). When age was treated as an independent covariate and included in the model, the difference in GABA+ between PM and RD women was no longer significant (P = .092).
Conclusion
Perimenopause is associated with decreased MPFC GABA+/Cr+PCr levels, which may contribute to the increased risk of experiencing a MD episode during PM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Alberta, Department of Psychiatry, Edmonton, AB, Canada.
- University of Alberta, Department of Biomedical Engineering, Edmonton, AB, Canada.
- University of Alberta, Department of Medical Genetics, Edmonton, AB, Canada.
- University of Alberta, Neuroscience and Mental Health Institute, Edmonton, AB, Canada.
- Northern Ontario School of Medicine, Division of Clinical Sciences, Psychiatry Section, Thunder Bay, ON, Canada.
- Lois Hole Hospital for Women, Royal Alexandra Hospital, Edmonton, AB, Canada.
ORCID-Profile: Kim H Tran
Zitieren
APA
Tran, K. H., Luki, J., Hanstock, S., Hanstock, C. C., Seres, P., Aitchison, K., Shandro, T., & Le Melledo, J. M. (2023). Decreased GABA+ Levels in the Medial Prefrontal Cortex of Perimenopausal Women: A 3T 1H-MRS Study. International Journal of Neuropsychopharmacology, 26(1), 32-41. https://doi.org/10.1093/ijnp/pyac066
Vancouver
Tran KH, Luki J, Hanstock S, Hanstock CC, Seres P, Aitchison K, et al. Decreased GABA+ Levels in the Medial Prefrontal Cortex of Perimenopausal Women: A 3T 1H-MRS Study. International Journal of Neuropsychopharmacology. 2023;26(1):32-41. doi:10.1093/ijnp/pyac066
BibTeX
@article{Tran2023,
author = {Tran, Kim H and Luki, Jessica and Hanstock, Sarah and Hanstock, Christopher C and Seres, Peter and Aitchison, Katherine and Shandro, Tami and Le Melledo, Jean-Michel},
title = {Decreased GABA+ Levels in the Medial Prefrontal Cortex of Perimenopausal Women: A 3T 1H-MRS Study},
journal = {International Journal of Neuropsychopharmacology},
year = {2023},
volume = {26},
number = {1},
pages = {32--41},
doi = {10.1093/ijnp/pyac066}
}
EUVIMED